Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations

Affiliations

¹ Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
² Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Wuhan Sixth Hospital Affiliated to Jianghan University, Wuhan, China.
⁴ Wuhan Mental Health Center, Wuhan, China.
⁵ Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China; CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Sciences, Shanghai, China; Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China. Electronic address: drminzhao@smhc.org.cn.

Haifeng Jiang et al. Eur Neuropsychopharmacol. 2020 Jun.

. 2020 Jun:35:136-137.

doi: 10.1016/j.euroneuro.2020.03.018. Epub 2020 Apr 13.

¹ Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
² Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Wuhan Sixth Hospital Affiliated to Jianghan University, Wuhan, China.
⁴ Wuhan Mental Health Center, Wuhan, China.
⁵ Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China; CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Sciences, Shanghai, China; Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China. Electronic address: drminzhao@smhc.org.cn.

No abstract available

References

1. China National Narcotic Control Committee, 2019. China Drug Report (2018).
1. Liu S., Yang L., Zhang C., Xiang Y.-.T., Liu Z., Hu S., Zhang B. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry. 2020 - PMC - PubMed
1. Matusow H., Benoit E., Elliott L., Dunlap E., Rosenblum A. Challenges to opioid treatment programs after hurricane sandy: patient and provider perspectives on preparation, impact, and recovery. Subst. Use Misuse. 2018;53:206–219. - PubMed
1. Qiu J., Shen B., Zhao M., Wang Z., Xie B., Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. General Psychiatry. 2020;33 - PMC - PubMed
1. Sullivan S.G., Wu Z., Rou K., Pang L., Luo W., Wang C., Cao X., Yin W., Liu E., Mi G. Who uses methadone services in China? Monitoring the world's largest methadone programme. Addiction. 2015;110:29–39. - PubMed